Zobrazeno 1 - 10
of 10
pro vyhledávání: '"JIN-NONG LI"'
Autor:
Ye Zhang, Jin-Nong Li, Lin-Hui Zhang, Bo Meng, Yi-Fan Li, Hang Xiao, Kolodeznikov Vasiliy Egorovich, Petrova Natalia Nikolaevna, Zi-Feng Zhang, Zhong-Hua Tang
Publikováno v:
Environmental Chemistry and Ecotoxicology, Vol 6, Iss , Pp 229-235 (2024)
Brominated flame retardants (BFRs), categorized as persistent organic pollutants (POPs) are difficult to degrade, exhibiting reproductive toxicity and carcinogenicity. Exposure to dust and soil particles containing BFRs may cause various health probl
Externí odkaz:
https://doaj.org/article/9b62735d818c466080f11bacb4255f7f
Autor:
Jin-Nong Li, Ye Zhang, Jian-Xin Wang, Hang Xiao, Anatoly Nikolaev, Yi-Fan Li, Zi-Feng Zhang, Zhong-Hua Tang
Publikováno v:
Toxics, Vol 11, Iss 8, p 695 (2023)
To obtain a comprehensive understanding about that occurrence, sources, and effects on human health of polycyclic aromatic hydrocarbons (PAHs) in road environmental samples from Harbin, concentrations of 32 PAHs in road dust, green belt soil, and par
Externí odkaz:
https://doaj.org/article/573a63b76c2c468daf67fc4edac3750f
Publikováno v:
Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 16 (2017)
Integrative Cancer Therapies, Vol 16 (2017)
Fuzheng Qingjie (FZQJ) granules, a compound Chinese medicine, have been used as an adjuvant therapy for alimentary tract cancers. However, the underlying anticancer mechanisms are still not well understood. In the present study, HepG2 cells were trea
Autor:
XU-ZHENG CHEN1, JIN-NONG LI2, YOU-QUAN ZHANG3, ZHI-YUN CAO1, ZHI-ZHEN LIU1, SU-QING WANG4, LIAN-MING LIAO1 llm@fjtcm.edu.cn, JIAN DU1 dujian@fjtcm.edu.cn
Publikováno v:
Molecular Medicine Reports. 2014, Vol. 9 Issue 6, p2381-2387. 7p.
Fuzheng Qingjie (FZQJ) is a polyherbal Chinese medicine that has previously been implemented as an adjuvant therapy for gastrointestinal cancer. The present study investigated whether FZQJ is able to potentiate the anticancer effect of cyclophosphami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4ed6a93fad2f8175d5dc0b5e6e2167
https://europepmc.org/articles/PMC5431466/
https://europepmc.org/articles/PMC5431466/
Autor:
Zhiyun Cao, Yun-Mei Huang, Dan Hu, Zhizhen Liu, Jin-Nong Li, Lianming Liao, Jian Du, Hai-xia Hu, Xuzheng Chen, You-Quan Zhang
Publikováno v:
Oncology reports. 32(6)
Jiedu Xiaozheng Yin (JXY) is a Chinese herbal decoction used to treat hepatocellular carcinoma (HCC). Previous studies have demonstrated that JXY can inhibit HCC cell proliferation via induction of G0/G1 phase arrest. In this study, we investigated w
Autor:
You-Quan Zhang, Jin-Nong Li, Xuzheng Chen, Su-Qing Wang, Zhi‑Zhen Liu, Lianming Liao, Jian Du, Zhiyun Cao
Publikováno v:
Molecular medicine reports. 9(6)
Fuzheng Qingjie (FZQJ) recipe is a polyherbal Chinese medicine capable of suppressing tumor growth and is used as an adjuvant therapy for various types of cancer. However, its anticancer mechanisms are yet to be fully elucidated. In the present study
Publikováno v:
Oncology Letters; May2017, Vol. 13 Issue 5, p3261-3268, 8p
Autor:
XU-ZHENG CHEN, ZHI-YUN CAO, JIN-NONG LI, HAI-XIA HU, YOU-QUAN ZHANG, YUN-MEI HUANG, ZHI-ZHEN LIU, DAN HU, LIAN-MING LIAO, JIAN DU
Publikováno v:
Oncology Reports; 2014, Vol. 32 Issue 6, p2710-2718, 9p
Autor:
Jin-Nong Li, Xiajing Li, Ruiqi Chen, Lianming Liao, Wenjuan Li, Baokang Huang, Dan Hu, Xuzheng Chen, Zhenhua Liu
Publikováno v:
BMC Complementary and Alternative Medicine
Background The Consolidated Standards for Reporting Trials (CONSORT) are aimed to standardize clinical trial reporting. Our objective is to compare the quality of randomized clinical trials (RCTs) of traditional Chinese medicine (TCM) published in 20